Does the use of mTOR inhibitors increase long-term mortality in kidney recipients?
- PMID: 22054299
- DOI: 10.1111/j.1600-6143.2011.03829.x
Does the use of mTOR inhibitors increase long-term mortality in kidney recipients?
Comment on
-
Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.Am J Transplant. 2012 Feb;12(2):379-87. doi: 10.1111/j.1600-6143.2011.03826.x. Epub 2011 Nov 4. Am J Transplant. 2012. PMID: 22054244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical